🔎 Trials Near Me

Beranda › Sklerosis Multipel › Illinois › Chicago

Uji klinis Sklerosis Multipel di Chicago, IL

15 studi untuk Sklerosis Multipel mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Menerima pesertaStudi observasional
  • TG Therapeutics Investigational Trial Site, Chicago
  • TG Therapeutics Investigational Trial Site, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06433752

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Menerima pesertaFase 2
  • Rush University Medical Center, Chicago
  • University of Chicago Medical Center, Chicago
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

Menerima pesertaFase 3
  • University of Chicago Medical Center, Chicago
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06408259

Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain

Menerima peserta
  • Shirley Ryan AbilityLab, Chicago
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07132775

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Menerima pesertaFase 3
  • Northwestern Memorial Hospital, Chicago
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT07225504

Ocrevus Zunovo for MS: Mixed Methods

Menerima pesertaStudi observasional
  • Northwestern Memorial Hospital, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Jul 2026 · NCT07710105

Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device

Menerima peserta
  • University of Illinois at Chicago, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT06410261

Functional Balance Intervention in Multiple Sclerosis

Menerima peserta
  • University of Illinois at Chicago, Chicago
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06341023

Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Menerima peserta
  • University of Illinois at Chicago, Chicago
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT05051618

Nomad P-KAFO Study

Menerima peserta
  • Shirley Ryan AbilityLab, Chicago
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT05644522

Intermittent Hypoxia in Persons With Multiple Sclerosis

Menerima peserta
  • Shirley Ryan AbilityLab, Chicago
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 20 Mar 2026 · NCT06276634

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Menerima pesertaStudi observasional
  • Northwestern Memorial Hospital, Chicago
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT07207148

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

Menerima pesertaFase 4
  • Northwestern Memorial Hospital, Chicago
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT07225361

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Menerima peserta
  • Shirley Ryan AbilityLab, Chicago
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 23 Feb 2026 · NCT06390930

Home Based Functional Balance Intervention for Multiple Sclerosis

Menerima peserta
  • University of Illinois at Chicago, Chicago
Usia 40 hingga 90 · Semua jenis kelamin · Diperbarui 21 Jan 2026 · NCT07355387

Uji klinis Sklerosis Multipel di kota lain

Studi lain di Chicago

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.